Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet comment on data, during a press conference at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, from the PRODIGE 7 trial.

This was a phase III randomised trial in which patients with stage IV non-metastatic colorectal cancer received surgical treatment with or without heated oxaliplatin chemotherapy.

For more on these results watch Dr Quenet present the data in the press conference here, watch Dr Quenets interview with ecancer here and read the news story here.